Start online and meet your provider
Answer a few questions about your health and goals — about two minutes. A licensed provider reviews everything 100% online.


Wellness · Arousal Peptide
Prescribed for low sexual desire in men and women. Activates brain pathways involved in desire.
Arousal Peptide is PT-141, also called bremelanotide, a synthetic analog of a hormone the body makes, alpha-melanocyte-stimulating hormone. It activates melanocortin receptors in the brain, a pathway involved in sexual desire and arousal, rather than acting on blood flow the way tadalafil and sildenafil do. At Pallas it's a compounded subcutaneous injection used before sexual activity, not every day, with the dose and how often you use it set by your clinician. One plan price covers your clinician, ongoing check-ins, care-team messaging, and your medication — shipped free and discreet.
PT-141 (bremelanotide), a synthetic analog of a hormone your body makes that acts on brain pathways involved in desire.
Nothing is charged until a clinician prescribes. $139 first month, then $179 every 4 weeks until you cancel; longer plans cost less.
Complete a short online intake. A US-licensed clinician reviews it and, if appropriate, prescribes it. It ships to your door.

What is Arousal Peptide
Arousal Peptide is PT-141, also called bremelanotide, a synthetic version of alpha-melanocyte-stimulating hormone, a hormone your body makes. It activates melanocortin receptors in the brain, chiefly the MC4 receptor, in pathways involved in sexual desire and arousal. Sildenafil and tadalafil work on blood flow; PT-141 works on the signal that comes before it. It is given as a small injection under the skin before sexual activity, and how often, and at what dose, is your clinician's call.
Arousal Peptide is prescribed for low sexual desire when a clinician decides it is appropriate. How it changes desire is not fully established, and research on the compounded injection is limited.
Who it's for
Desire that has fallen off, in men or women, when a clinician decides a medication is appropriate.
Erections that have not responded well to tadalafil or sildenafil, or when those tablets aren't an option.
A small injection before sexual activity rather than a daily medication, with the frequency set by your clinician.
What the research says
In a small double-blind, placebo-controlled study, intranasal PT-141 produced erectile responses that were statistically significant against placebo in healthy men and in men with mild to moderate erectile dysfunction, with flushing and nausea the most common side effects.1 It was a small, early study of the nasal form, which is not what Pallas dispenses; the compounded injection has not been studied the same way.
What it does
Individual experiences vary.
Answer a few questions about your health and goals — about two minutes. A licensed provider reviews everything 100% online.

If eligible, your provider writes a prescription and medication ships free and discreet from a US-licensed pharmacy — often within a week.

We stay with you the whole way, with regular check-ins and on-demand messaging with your care team.


Pharmacy & safety
Your medication is prepared for you once it's prescribed, then shipped to your door.
PT-141 (bremelanotide), a synthetic analog of a hormone your body makes that acts on brain pathways involved in desire.
Nothing is charged until a clinician prescribes. $139 first month, then $179 every 4 weeks until you cancel; longer plans cost less.
Complete a short online intake. A US-licensed clinician reviews it and, if appropriate, prescribes it. It ships to your door.
As a small injection under the skin before sexual activity, not every day. Your clinician sets the dose and how often you may use it; never more than one dose in 24 hours.
Nausea is the most common, then flushing, headache and injection-site reactions. It briefly raises blood pressure and slows the heart rate for a few hours after a dose.
It is not prescribed for uncontrolled high blood pressure or known heart disease, and frequent use can darken patches of skin, more often on darker skin. Your clinician decides.
That's a clinical decision. Your clinician reviews your health history, current medications and goals and decides whether Arousal Peptide is appropriate for you.
No. Arousal Peptide is compounded PT-141 (bremelanotide), prepared per-patient by state-licensed US compounding pharmacies, and it is not FDA-approved.
From our members
Feedback from Pallas members across our programs.
Quotes from Pallas members, shared with permission; names abbreviated for privacy. Testimonials reflect individual experiences — individual results vary.
$139 first month

Compounded PT-141 is prepared per-patient by state-licensed US compounding pharmacies and is not FDA-approved. The research cited describes the molecule as studied, not the compounded preparation Pallas dispenses.